Hub : Traits :

Heel bone mineral density (BMD) T-score, automated (right)

1022 significantly associated models · 277 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	752566	1567206	1	1	4.4e-08	4.9e-07	1.0e+00	100	KLHL17
2	1	7686056	9571422	3	1	2.0e-14	6.8e-12	3.2e-01	98	RERE
3	1	15123100	16844848	6	2	6.0e-11	4.0e-10	6.9e-01	100	C1orf134 CASP9
4	1	18972776	20503710	1	1	1.6e-07	2.3e-08	3.0e-02	85	CAPZB
5	1	22197336	22718991	1	1	1.3e-16	5.0e-22	2.0e-24	-12	WNT4
6	1	37764586	39167106	1	1	1.9e-08	3.7e-07	7.1e-01	100	FHL3
7	1	112312154	114196883	4	1	6.2e-16	7.0e-15	1.0e+00	100	WNT2B
8	1	118878656	120380990	1	1	1.0e-07	1.4e-09	7.6e-06	45	WARS2
9	1	219166366	220808921	1	1	4.6e-09	9.7e-10	6.8e-02	91	SLC30A10
10	1	239954252	241470634	1	1	9.9e-41	1.2e-53	1.3e-16	71	GREM2
11	2	39636469	41534961	1	1	3.5e-09	1.7e-12	7.1e-08	42	SLC8A1
12	2	41579722	42984340	1	1	2.9e-12	1.9e-25	3.3e-15	43	PKDCC
13	2	53583159	55895321	9	9	2.1e-46	5.6e-66	NaN	NaN	AC092839.1 AC093110.3 ACYP2 C2orf73 EML6 RPL23AP32 SPTBN1
14	2	64168232	65573478	1	1	1.5e-07	4.7e-08	3.5e-02	85	SERTAD2
15	2	202200575	203592180	1	1	5.9e-10	6.5e-30	6.4e-27	11	FZD7
16	3	48012797	50800146	23	1	2.9e-12	7.5e-12	5.1e-02	92	AMT
17	3	155695485	157456920	4	2	1.7e-15	1.4e-13	3.5e-01	98	LEKR1 TIPARP
18	4	69713	2058475	14	12	2.8e-36	6.0e-33	NaN	NaN	CRIPAK FGFRL1 IDUA MYL5 RP11-20I20.4 TMEM175
19	4	57587795	58088682	1	1	2.9e-09	4.8e-10	1.0e+00	100	C4orf14
20	4	85698680	89692911	6	4	1.5e-12	5.7e-12	1.0e+00	100	HSD17B13 IBSP RP13-514E23.2 SPP1
21	4	144882744	147278056	3	2	1.4e-12	2.5e-13	4.1e-03	85	HHIP-AS1 MMAA
22	5	39132847	39670061	1	1	7.1e-09	3.5e-09	1.6e-04	59	DAB2
23	5	42179899	42967215	1	1	1.8e-08	2.0e-08	4.0e-01	98	GHR
24	5	53906103	55410585	1	1	2.5e-07	1.2e-06	9.4e-01	100	SKIV2L2
25	5	80008704	80761967	1	1	1.3e-12	7.8e-13	1.0e+00	100	RASGRF2
26	6	44079216	46043561	1	1	2.4e-20	1.7e-24	6.5e-11	59	SUPT3H
27	6	73710903	75236060	1	1	3.1e-10	4.8e-13	3.6e-04	76	CD109
28	6	126892049	128307725	2	1	6.9e-74	4.5e-88	9.2e-16	84	RSPO3
29	6	132394840	134546685	5	3	2.6e-13	8.8e-42	8.6e-23	47	C6orf192 EYA4
30	6	151118271	153120904	4	9	5.3e-83	1.8e-69	1.4e-03	97	C6orf97 CCDC170 ESR1
31	7	26871554	28568019	3	1	2.3e-10	1.9e-15	1.6e-11	28	AC004549.6
32	7	37260712	38687833	1	4	4.9e-25	5.8e-41	5.5e-03	96	EPDR1
33	7	91380845	93160671	2	1	6.3e-10	2.6e-09	2.8e-01	97	CDK6
34	7	119892061	121729795	5	7	1.8e-235	0.0e+00	NaN	NaN	C7orf58 CPED1 FAM3C
35	7	148285882	149691341	1	1	1.6e-07	1.0e-07	1.0e+00	100	RP4-800G7.2
36	7	150034951	151443931	1	1	9.1e-08	1.7e-07	2.5e-02	82	ABCB8
37	8	8092025	13120332	39	10	1.6e-22	1.9e-26	NaN	NaN	AF131215.9 ERI1 FAM167A FAM66D FAM85A FLJ10661 SGK223
38	8	70890495	72399360	1	1	1.0e-07	8.3e-10	1.9e-08	16	XKR9
39	9	96102832	97759920	3	2	1.0e-08	3.4e-09	1.3e-02	82	BARX1 ZNF169
40	10	30887952	31565621	1	1	1.8e-07	2.3e-25	1.4e-19	24	ZNF438
41	10	122801759	124407934	2	2	3.2e-10	8.0e-10	7.4e-03	81	RP11-500G22.2
42	11	16072004	17469466	1	1	1.4e-07	4.5e-10	4.0e-05	57	C11orf58
43	11	26818083	28220506	1	1	3.2e-13	3.2e-27	5.0e-17	40	LIN7C
44	11	34460769	35949179	1	1	1.6e-11	4.9e-12	1.0e+00	100	CD44
45	11	46010847	48285906	13	1	1.6e-16	6.9e-17	1.0e+00	100	ARFGAP2
46	11	59239839	60645214	4	1	3.3e-10	1.3e-10	1.6e-03	76	MS4A4A
47	11	60869481	62346131	4	1	2.4e-10	3.4e-08	4.3e-01	98	FADS2
48	11	64669105	66714782	4	2	2.0e-12	5.2e-08	9.1e-01	100	RP11-867G23.1 SIPA1
49	11	67533195	69623641	8	3	1.5e-16	9.2e-21	1.6e-03	89	GAL SAPS3 TPCN2
50	11	111354161	112921923	2	1	1.2e-30	3.2e-48	2.6e-19	62	RP11-356J5.12
51	11	114340771	116072203	1	1	9.4e-12	9.4e-16	1.9e-05	72	CADM1
52	12	191619	1368535	1	1	2.0e-07	1.1e-06	7.1e-01	99	B4GALNT3
53	12	25417418	26928426	1	1	5.9e-09	2.2e-07	6.3e-02	87	RASSF8
54	12	49827409	51256065	1	1	2.2e-07	3.9e-05	2.8e-01	93	CERS5
55	12	53414010	53932834	1	1	3.1e-07	8.2e-08	1.0e+00	100	ESPL1
56	12	123558705	125155900	3	1	3.7e-09	1.0e-06	1.7e-01	92	DNAH10
57	13	49557805	50962458	1	1	5.3e-09	1.4e-06	4.3e-03	65	EBPL
58	13	98746497	100437143	2	3	1.4e-17	3.3e-19	4.9e-02	95	DOCK9 DOCK9-AS2
59	14	34754717	36242995	2	1	1.4e-10	1.4e-10	1.0e+00	100	SRP54
60	14	53731553	55118795	1	1	2.4e-34	2.3e-34	8.7e-07	84	BMP4
61	14	60168943	61664530	1	1	3.7e-08	6.4e-08	3.3e-01	97	C14orf39
62	14	103161201	104892153	8	1	8.0e-17	4.3e-17	1.0e+00	100	MARK3
63	15	51255019	51946100	2	2	2.7e-13	2.2e-14	2.2e-04	77	CYP19A1 GLDN
64	15	90208219	91886448	3	1	1.4e-08	5.8e-09	1.2e-01	93	IQGAP1
65	16	86671	1100776	2	2	6.8e-08	7.8e-09	5.7e-02	89	RGS11 TMEM8A
66	16	66545982	68125316	5	1	1.6e-10	6.3e-14	4.4e-05	70	TPPP3
67	17	1717695	2453908	1	1	1.6e-16	2.3e-20	5.9e-07	71	SMG6
68	17	27658233	28161482	1	1	1.5e-07	5.2e-07	5.2e-01	98	GIT1
69	17	41393295	42998534	7	1	6.9e-14	3.3e-17	1.5e-12	30	HDAC5
70	18	12966058	14385836	2	2	6.9e-08	6.3e-24	2.6e-14	43	FAM210A RNMT
71	19	32482073	34392158	9	12	4.7e-47	4.8e-46	NaN	NaN	CEP89 CTD-2538C1.2 GPATCH1 RHPN2 WDR88
72	19	41479309	42009673	1	1	2.8e-07	7.1e-05	3.3e-03	45	AXL
73	20	10374093	10903755	1	1	3.1e-09	6.5e-13	7.0e-11	18	JAG1
74	20	32819871	34556216	5	1	7.0e-10	1.1e-09	1.0e+00	100	MYH7B
75	20	39567774	40193393	1	1	2.3e-08	8.4e-11	9.1e-04	74	ZHX3
76	22	19003938	20330744	1	1	8.0e-09	2.2e-40	2.9e-33	18	SEPT5
77	22	27675538	30261219	5	9	6.8e-23	5.8e-23	1.0e+00	100	C22orf31 KREMEN1 TTC28 XBP1
78	22	38388203	39770597	1	1	2.1e-07	9.7e-07	6.2e-01	99	TOMM22
79	22	40789606	42301748	2	1	9.7e-08	4.1e-08	1.0e+00	100	L3MBTL2
80	22	49550794	50999182	2	1	7.5e-09	4.1e-09	9.3e-02	92	ALG12

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder (2018)	0.92	1	0	0.0	0.00	1.0e+00	MYH7B
Bipolar Disorder or Schizophrenia	1.12	2	0	0.0	0.98	2.1e-02	FLJ10661 MYH7B
Depressed Affect (Nagel 2018)	0.96	2	1	2.2	0.00	1.0e+00	ARFGAP2 RERE
Depression (Nagel 2018)	1.09	1	0	0.0	0.00	1.0e+00	RERE
Intelligence (Savage-Jansen 2018)	0.63	2	0	0.0	0.00	1.0e+00	AMT MARK3
Neuroticism (Nagel 2018)	0.93	3	0	0.0	0.00	1.0e+00	ALG12 ARFGAP2 RERE
Schizophrenia (2018)	1.14	1	0	0.0	0.00	1.0e+00	RERE
Alzheimer’s Disease (including proxy)	1.24	1	1	2.2	0.00	1.0e+00	MS4A4A
Crohns Disease (2017)	1.20	5	1	2.2	0.38	5.3e-01	AMT MARK3 RHPN2 RSPO3 ZHX3
Irritable Bowel Disease (IBD)	1.00	3	1	2.2	0.00	1.0e+00	AMT MARK3 ZHX3
Ulcerative Colitis (UC)	0.84	1	0	0.0	0.00	1.0e+00	ZHX3
Reaction Time	0.94	2	0	0.0	0.00	1.0e+00	ARFGAP2 DNAH10
Breast Cancer	1.78	2	1	2.2	0.24	6.9e-01	C6orf97 RP11-500G22.2
Bipolar Disorder (2011)	1.15	1	0	0.0	0.00	1.0e+00	MYH7B
Coronary Artery Disease (CAD)	1.42	1	0	0.0	0.00	1.0e+00	DNAH10
Crohns Disease (2012)	1.18	1	1	2.2	0.00	1.0e+00	AMT
HDL Cholesterol	1.42	5	2	4.4	-0.29	6.3e-01	ARFGAP2 DNAH10 FADS2 RSPO3 SIPA1
LDL Cholesterol	1.10	1	1	2.2	0.00	1.0e+00	FADS2
Lupus	1.34	2	1	2.2	0.00	1.0e+00	CD44 FLJ10661
Neuroticism (2016)	2.30	6	6	13.3	-0.99	9.1e-07	AF131215.9 ERI1 FAM66D FAM85A FLJ10661 SGK223
Primary Biliary Cirrhosis	1.49	1	0	0.0	0.00	1.0e+00	IDUA
Rheumatoid Arthritis	1.31	2	0	0.0	0.00	1.0e+00	CDK6 FADS2
Schizophrenia (2014)	1.38	3	2	4.4	0.24	6.9e-01	FLJ10661 RERE SMG6
Triglycerides	1.55	4	1	2.2	0.20	8.0e-01	DNAH10 FADS2 HSD17B13 RSPO3
Blood Eosinophil Count	0.80	17	8	17.8	0.16	5.4e-01	AMT C1orf134 C4orf14 C6orf97 CDK6 EBPL EML6 FADS2 L3MBTL2 MARK3 RERE RP11-867G23.1 RP4-800G7.2 SAPS3 SIPA1 TPPP3 ZNF169
Blood Platelet Count	1.15	25	15	33.3	0.20	3.1e-01	ALG12 ARFGAP2 C1orf134 C4orf14 CAPZB CDK6 CERS5 CTD-2538C1.2 DOCK9 FADS2 GLDN HDAC5 HSD17B13 KREMEN1 MARK3 RHPN2 RP13-514E23.2 RSPO3 SEPT5 SERTAD2 SMG6 TIPARP TOMM22 WNT2B ZHX3
Blood Red Count	0.97	25	13	28.9	-0.18	3.7e-01	ABCB8 AC093110.3 AMT C11orf58 C14orf39 CCDC170 CERS5 DNAH10 EML6 ESPL1 FADS2 FZD7 GIT1 HDAC5 MARK3 RGS11 RHPN2 RPL23AP32 RSPO3 SAPS3 SERTAD2 SMG6 SPTBN1 TIPARP TMEM8A
Blood White Count	1.03	20	8	17.8	-0.26	2.7e-01	C4orf14 CDK6 CERS5 CYP19A1 DNAH10 DOCK9-AS2 EYA4 FADS2 GIT1 IDUA IQGAP1 KREMEN1 RERE RP13-514E23.2 SMG6 SPTBN1 TIPARP TPCN2 ZHX3 ZNF169
Heel T-Score	45.93	117	115	255.6	0.99	1.2e-131	ABCB8 AC004549.6 AC092839.1 AC093110.3 ACYP2 ALG12 AMT ARFGAP2 AXL B4GALNT3 BARX1 BMP4 C11orf58 C14orf39 C1orf134 C22orf31 C2orf73 C4orf14 C6orf192 C6orf97 C7orf58 CADM1 CAPZB CASP9 CCDC170 CD109 CD44 CDK6 CEP89 CERS5 CPED1 CRIPAK CTD-2538C1.2 CYP19A1 DAB2 DNAH10 DOCK9 DOCK9-AS2 EBPL EML6 EPDR1 ERI1 ESPL1 ESR1 EYA4 FADS2 FAM210A FAM3C FGFRL1 FHL3 FZD7 GAL GHR GIT1 GLDN GPATCH1 GREM2 HDAC5 HHIP-AS1 HSD17B13 IBSP IDUA IQGAP1 JAG1 KLHL17 KREMEN1 L3MBTL2 LEKR1 LIN7C MARK3 MMAA MS4A4A MYH7B MYL5 PKDCC RASGRF2 RASSF8 RERE RGS11 RHPN2 RNMT RP11-20I20.4 RP11-356J5.12 RP11-500G22.2 RP11-867G23.1 RP13-514E23.2 RP4-800G7.2 RPL23AP32 RSPO3 SAPS3 SEPT5 SERTAD2 SIPA1 SKIV2L2 SLC30A10 SLC8A1 SMG6 SPP1 SPTBN1 SRP54 SUPT3H TIPARP TMEM175 TMEM8A TOMM22 TPCN2 TPPP3 TTC28 WARS2 WDR88 WNT2B WNT4 XBP1 XKR9 ZHX3 ZNF169 ZNF438
BMI	0.69	11	5	11.1	0.27	4.2e-01	AMT CADM1 CERS5 DNAH10 GIT1 L3MBTL2 MARK3 MYH7B SAPS3 SMG6 WARS2
Height	2.08	55	42	93.3	0.03	8.2e-01	AC092839.1 ALG12 ARFGAP2 B4GALNT3 C14orf39 C1orf134 C4orf14 C7orf58 CADM1 CAPZB CDK6 CPED1 CRIPAK CYP19A1 DAB2 DNAH10 DOCK9 EBPL EPDR1 EYA4 FADS2 FGFRL1 FHL3 GAL GHR GIT1 HHIP-AS1 HSD17B13 IBSP IDUA IQGAP1 KREMEN1 MARK3 MS4A4A MYH7B RGS11 RHPN2 RP11-20I20.4 RP11-500G22.2 RP13-514E23.2 RP4-800G7.2 RPL23AP32 SAPS3 SIPA1 SLC8A1 SPP1 SPTBN1 SUPT3H TOMM22 TPCN2 TPPP3 WARS2 WNT2B WNT4 ZNF169
Waist Hip Ratio (WHR)	3.37	23	13	28.9	0.06	7.5e-01	ABCB8 AMT C7orf58 CPED1 CRIPAK CYP19A1 DNAH10 FAM3C FGFRL1 HHIP-AS1 IDUA KREMEN1 MYH7B MYL5 RSPO3 SIPA1 SLC30A10 TIPARP TMEM175 TPCN2 WARS2 WNT4 XKR9
Systolic Blood Pressure	1.42	14	7	15.6	0.23	4.0e-01	ALG12 ARFGAP2 BMP4 C1orf134 C6orf97 CASP9 CDK6 CRIPAK ESR1 FHL3 RERE RP13-514E23.2 SIPA1 WNT2B
Smoking Status	0.85	3	1	2.2	0.00	1.0e+00	C4orf14 MARK3 RERE
Allergy or Eczema	1.13	4	2	4.4	0.29	7.1e-01	IQGAP1 RERE RP11-867G23.1 RP4-800G7.2
Cardiovascular Disease	1.30	7	2	4.4	0.20	5.5e-01	CDK6 GIT1 KREMEN1 MARK3 RP13-514E23.2 RPL23AP32 SIPA1
Hypothyroidism (self reported)	1.08	3	1	2.2	0.00	1.0e+00	FADS2 FHL3 GIT1
Respiratory disease	1.19	4	2	4.4	-0.52	4.8e-01	C4orf14 FADS2 RERE ZNF169
Type 2 Diabetes (T2D) (2018)	1.06	1	0	0.0	0.00	1.0e+00	MARK3
Lung FEV1/FVC ratio	1.91	11	8	17.8	-0.41	2.1e-01	BMP4 C1orf134 DOCK9-AS2 ERI1 FAM3C GIT1 HHIP-AS1 L3MBTL2 RERE SERTAD2 SMG6
Lung FVC	1.07	12	7	15.6	0.05	8.8e-01	BMP4 C4orf14 CD109 CERS5 CYP19A1 EBPL GIT1 MYH7B SAPS3 WNT2B WNT4 ZNF438
Neuroticism	0.88	2	0	0.0	0.00	1.0e+00	ARFGAP2 RERE
Chronotype (morning person)	1.26	2	2	4.4	0.52	4.8e-01	CRIPAK RP11-500G22.2
Hair Pigment	0.35	13	9	20.0	0.40	1.7e-01	ARFGAP2 C14orf39 C4orf14 CD44 FADS2 GAL KREMEN1 LIN7C MARK3 MYH7B SAPS3 SIPA1 TPCN2
Tanning	0.36	2	2	4.4	0.00	1.0e+00	LEKR1 MYH7B
Hand grip strength (left)	1.40	4	2	4.4	0.33	4.2e-01	C7orf58 CRIPAK DNAH10 SAPS3
Number of treatments/medications taken	0.95	1	0	0.0	0.00	1.0e+00	FADS2
Sensitivity / hurt feelings	1.27	4	3	6.7	-0.99	2.6e-04	AF131215.9 ERI1 FLJ10661 SGK223
Frequency of depressed mood in last 2 weeks	1.50	1	0	0.0	0.00	1.0e+00	ERI1
Relative age of first facial hair	0.94	2	0	0.0	0.00	1.0e+00	CYP19A1 SIPA1
Systolic blood pressure, automated reading	1.85	13	7	15.6	0.58	2.0e-02	AF131215.9 CDK6 ERI1 ESR1 FHL3 FLJ10661 MYH7B RERE RP13-514E23.2 SGK223 SIPA1 TMEM175 WNT2B
Angina	1.18	1	0	0.0	0.00	1.0e+00	CADM1
Diabetes (mother)	1.24	1	0	0.0	0.00	1.0e+00	ZHX3
Impedance of leg (right)	1.80	22	13	28.9	-0.58	2.5e-03	AC092839.1 AF131215.9 C1orf134 CADM1 CDK6 ERI1 FAM66D FAM85A FLJ10661 GAL GHR IBSP L3MBTL2 MARK3 RPL23AP32 SAPS3 SGK223 SMG6 WARS2 WNT2B WNT4 ZHX3
Leg fat-free mass (left)	1.95	26	18	40.0	0.34	6.4e-02	ABCB8 AF131215.9 ARFGAP2 B4GALNT3 C14orf39 C1orf134 CDK6 CRIPAK DAB2 DOCK9 EBPL ERI1 FHL3 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SGK223 SMG6 SUPT3H WNT4
Trunk fat percentage	1.12	11	6	13.3	-0.19	5.9e-01	AC092839.1 AMT CERS5 CPED1 DNAH10 GIT1 HDAC5 RERE SPTBN1 WNT2B ZHX3
Hand grip strength (right)	1.53	4	3	6.7	-0.62	7.5e-02	C7orf58 CRIPAK DNAH10 RP11-20I20.4
Maternal smoking around birth	1.02	1	0	0.0	0.00	1.0e+00	MARK3
Fed-up feelings	1.62	5	3	6.7	-0.99	7.8e-07	AF131215.9 ARFGAP2 ERI1 FLJ10661 SGK223
Relative age voice broke	0.77	1	0	0.0	0.00	1.0e+00	AMT
Age when periods started (menarche)	1.09	3	1	2.2	0.00	1.0e+00	L3MBTL2 RP11-500G22.2 TIPARP
Bilateral oophorectomy (both ovaries removed)	1.23	1	1	2.2	0.00	1.0e+00	WNT4
Heel bone mineral density (BMD) T-score, automated (left)	33.62	123	101	224.4	1.00	1.1e-187	ABCB8 AC004549.6 AC092839.1 AC093110.3 ACYP2 AF131215.9 ALG12 AMT ARFGAP2 AXL B4GALNT3 BARX1 BMP4 C11orf58 C14orf39 C1orf134 C22orf31 C2orf73 C4orf14 C6orf192 C6orf97 C7orf58 CADM1 CAPZB CASP9 CCDC170 CD109 CD44 CDK6 CEP89 CERS5 CPED1 CRIPAK CTD-2538C1.2 CYP19A1 DAB2 DNAH10 DOCK9 DOCK9-AS2 EBPL EML6 EPDR1 ERI1 ESPL1 ESR1 EYA4 FADS2 FAM167A FAM210A FAM3C FAM66D FAM85A FGFRL1 FHL3 FLJ10661 FZD7 GAL GHR GIT1 GLDN GPATCH1 GREM2 HDAC5 HHIP-AS1 HSD17B13 IBSP IDUA IQGAP1 JAG1 KLHL17 KREMEN1 L3MBTL2 LEKR1 LIN7C MARK3 MMAA MS4A4A MYH7B MYL5 PKDCC RASGRF2 RASSF8 RERE RGS11 RHPN2 RNMT RP11-20I20.4 RP11-356J5.12 RP11-500G22.2 RP11-867G23.1 RP13-514E23.2 RP4-800G7.2 RPL23AP32 RSPO3 SAPS3 SEPT5 SERTAD2 SGK223 SIPA1 SKIV2L2 SLC30A10 SLC8A1 SMG6 SPP1 SPTBN1 SRP54 SUPT3H TIPARP TMEM175 TMEM8A TOMM22 TPCN2 TPPP3 TTC28 WARS2 WDR88 WNT2B WNT4 XBP1 XKR9 ZHX3 ZNF169 ZNF438
Serious illness, injury or assault to yourself	1.27	1	0	0.0	0.00	1.0e+00	SPTBN1
High blood pressure	1.86	10	4	8.9	-0.09	7.3e-01	AF131215.9 ARFGAP2 C6orf97 ERI1 FLJ10661 KREMEN1 RP13-514E23.2 SGK223 SIPA1 SMG6
Hayfever, allergic rhinitis or eczema	1.08	2	2	4.4	0.00	1.0e+00	IQGAP1 RERE
Medication: Levothyroxine sodium	1.37	4	1	2.2	-1.00	2.8e-05	AF131215.9 FADS2 FLJ10661 SGK223
Sitting height	2.25	28	21	46.7	0.21	2.3e-01	ARFGAP2 B4GALNT3 C14orf39 CAPZB CD109 CDK6 CRIPAK DAB2 DOCK9 EBPL EPDR1 ERI1 EYA4 FHL3 GAL HHIP-AS1 HSD17B13 IBSP KREMEN1 MYH7B RGS11 RP11-20I20.4 SAPS3 SUPT3H TIPARP TPPP3 WNT4 ZNF169
Body mass index (BMI)	1.22	11	8	17.8	0.75	3.1e-03	AF131215.9 AMT CADM1 DNAH10 ERI1 FAM85A FLJ10661 GIT1 MARK3 SGK223 SMG6
Impedance of leg (left)	1.81	22	13	28.9	-0.54	5.3e-03	ABCB8 AC092839.1 AF131215.9 C1orf134 CADM1 CDK6 ERI1 FAM66D FAM85A FLJ10661 GAL GHR IBSP L3MBTL2 MARK3 RPL23AP32 SAPS3 SGK223 SMG6 WARS2 WNT2B WNT4
Leg predicted mass (left)	1.94	26	17	37.8	0.34	6.5e-02	ABCB8 AF131215.9 ARFGAP2 B4GALNT3 C14orf39 C1orf134 CDK6 CRIPAK DAB2 DOCK9 EBPL ERI1 FHL3 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SGK223 SMG6 SUPT3H WNT4
Trunk fat mass	1.18	9	6	13.3	0.05	9.0e-01	AMT CDK6 CERS5 DNAH10 ERI1 HDAC5 RERE WNT2B ZHX3
Waist circumference	1.08	10	2	4.4	0.30	4.0e-01	ABCB8 AMT CADM1 CDK6 GIT1 MARK3 RSPO3 SIPA1 SMG6 TIPARP
Past tobacco smoking	0.99	2	1	2.2	0.00	1.0e+00	C4orf14 MYH7B
Alcohol usually taken with meals	1.08	1	0	0.0	0.00	1.0e+00	TPCN2
Nervous feelings	1.93	5	5	11.1	-0.99	2.1e-06	AF131215.9 ERI1 FAM85A FLJ10661 SGK223
Hearing difficulty/problems with background noise	1.29	1	0	0.0	0.00	1.0e+00	ARFGAP2
Hair/balding pattern: Pattern 2	1.54	1	1	2.2	0.00	1.0e+00	EYA4
Forced vital capacity (FVC)	1.72	18	8	17.8	0.19	3.8e-01	ARFGAP2 BARX1 C4orf14 CDK6 CRIPAK CYP19A1 EBPL FGFRL1 FHL3 GAL GIT1 HHIP-AS1 RP11-20I20.4 SAPS3 SIPA1 WNT4 ZNF169 ZNF438
Allergy	1.05	3	2	4.4	0.00	1.0e+00	FADS2 IQGAP1 RERE
Hayfever/allergic rhinitis (self-reported)	1.06	1	0	0.0	0.00	1.0e+00	IQGAP1
Illnesses of siblings	1.41	2	0	0.0	0.00	1.0e+00	CADM1 GIT1
Neuroticism score	2.17	6	6	13.3	-1.00	1.9e-09	AF131215.9 ERI1 FAM66D FAM85A FLJ10661 SGK223
Weight	1.53	20	5	11.1	0.40	6.1e-02	AF131215.9 AMT B4GALNT3 C14orf39 CDK6 CERS5 CRIPAK DAB2 ERI1 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B SAPS3 SGK223 SMG6 WNT2B WNT4
Impedance of arm (right)	2.07	27	16	35.6	-0.27	1.2e-01	ABCB8 AF131215.9 BARX1 C4orf14 CADM1 CRIPAK DNAH10 ERI1 FAM66D FAM85A FLJ10661 FZD7 GHR IBSP KREMEN1 L3MBTL2 MARK3 MYH7B RP11-20I20.4 RPL23AP32 SAPS3 SGK223 SMG6 SPTBN1 TIPARP WARS2 WNT2B
Arm fat percentage (right)	1.05	9	4	8.9	0.82	3.9e-03	AMT CERS5 DNAH10 ERI1 FLJ10661 GIT1 HDAC5 MARK3 SGK223
Trunk fat-free mass	2.26	28	23	51.1	0.23	1.8e-01	ABCB8 ARFGAP2 B4GALNT3 C14orf39 C4orf14 CAPZB CDK6 CRIPAK DAB2 DNAH10 DOCK9 EBPL ERI1 FGFRL1 FHL3 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SMG6 SUPT3H TPPP3 WNT4 ZNF169
Hip circumference	1.38	15	8	17.8	-0.31	2.5e-01	AF131215.9 CDK6 DNAH10 ERI1 EYA4 FLJ10661 HHIP-AS1 IBSP MYH7B RSPO3 TOMM22 TPCN2 WARS2 WNT4 ZHX3
Alcohol intake versus 10 years previously	1.08	1	0	0.0	0.00	1.0e+00	SIPA1
Worrier / anxious feelings	2.14	6	6	13.3	-0.99	1.2e-07	AF131215.9 ERI1 FAM66D FAM85A FLJ10661 SGK223
Frequency of tiredness / lethargy in last 2 weeks	1.13	1	0	0.0	0.00	1.0e+00	AMT
Hair/balding pattern: Pattern 3	1.30	2	2	4.4	0.00	1.0e+00	EYA4 ZHX3
Number of live births	1.29	3	2	4.4	0.00	1.0e+00	C6orf97 FADS2 WNT4
Forced expiratory volume in 1-second (FEV1)	1.98	16	7	15.6	-0.15	5.0e-01	BARX1 C4orf14 CDK6 CRIPAK EBPL ERI1 FAM85A FHL3 FLJ10661 GAL HHIP-AS1 RP11-20I20.4 SAPS3 WNT4 ZNF169 ZNF438
Pulse rate	1.57	3	1	2.2	0.00	1.0e+00	AMT LEKR1 TOMM22
Qualifications: A levels/AS levels or equivalent	0.85	2	0	0.0	0.00	1.0e+00	AMT FZD7
Asthma	1.23	2	2	4.4	0.00	1.0e+00	FADS2 RERE
Forced expiratory volume in 1-second (FEV1), Best measure	1.98	16	4	8.9	-0.08	7.3e-01	BARX1 C4orf14 CDK6 CRIPAK EBPL ERI1 FAM66D FHL3 GAL HHIP-AS1 RP11-20I20.4 SAPS3 SGK223 WNT4 ZNF169 ZNF438
Impedance of arm (left)	1.90	27	13	28.9	-0.29	1.0e-01	ABCB8 AF131215.9 BARX1 C4orf14 CADM1 DNAH10 ERI1 FAM66D FAM85A FLJ10661 FZD7 GHR IBSP KREMEN1 L3MBTL2 MARK3 MYH7B RP11-20I20.4 RPL23AP32 SAPS3 SGK223 SMG6 SPTBN1 SRP54 TIPARP WARS2 WNT2B
Arm fat mass (right)	1.15	14	5	11.1	0.64	7.2e-03	AF131215.9 AMT CADM1 CDK6 CERS5 DNAH10 ERI1 FAM85A FLJ10661 GIT1 HDAC5 MARK3 SGK223 SMG6
Trunk predicted mass	2.25	28	23	51.1	0.23	1.8e-01	ABCB8 ARFGAP2 B4GALNT3 C14orf39 C4orf14 CAPZB CDK6 CRIPAK DAB2 DNAH10 DOCK9 EBPL ERI1 FGFRL1 FHL3 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SMG6 SUPT3H TPPP3 WNT4 ZNF169
Standing height	2.07	42	30	66.7	0.05	7.2e-01	ARFGAP2 B4GALNT3 C14orf39 C1orf134 C7orf58 CAPZB CDK6 CRIPAK DAB2 DNAH10 DOCK9 EBPL EPDR1 ERI1 EYA4 FADS2 FGFRL1 FHL3 FLJ10661 GAL GHR GIT1 HHIP-AS1 HSD17B13 IBSP IQGAP1 MARK3 MYH7B RGS11 RP11-20I20.4 RP13-514E23.2 RP4-800G7.2 SAPS3 SGK223 SIPA1 SUPT3H TOMM22 TPCN2 TPPP3 WNT2B WNT4 ZNF169
Tense / 'highly strung'	2.00	5	2	4.4	-0.78	2.2e-02	AF131215.9 ERI1 FLJ10661 RERE SGK223
Hair/balding pattern: Pattern 4	1.57	6	3	6.7	-0.04	9.4e-01	FADS2 IQGAP1 MYH7B TPPP3 WARS2 ZHX3
Birth weight of first child	1.32	3	0	0.0	0.00	1.0e+00	TIPARP WNT4 ZNF169
Peak expiratory flow (PEF)	1.94	8	1	2.2	-0.72	1.9e-02	BMP4 ERI1 FAM66D FAM85A FLJ10661 HHIP-AS1 SAPS3 SGK223
Medication: Paracetamol	1.09	1	0	0.0	0.00	1.0e+00	ERI1
Gout (self-reported)	0.97	2	0	0.0	0.00	1.0e+00	IBSP SIPA1
Hypothyroidism/myxoedema (self-reported)	1.69	6	2	4.4	-0.99	3.4e-07	AF131215.9 ERI1 FADS2 FAM85A FLJ10661 SGK223
Medication: Amlodipine	1.40	1	0	0.0	0.00	1.0e+00	SIPA1
Birth weight	2.06	6	2	4.4	0.53	1.8e-01	CDK6 KREMEN1 RSPO3 TIPARP TPPP3 WNT4
Chronic bronchitis/emphysema (mother)	1.13	1	0	0.0	0.00	1.0e+00	HHIP-AS1
High blood pressure (siblings)	1.45	2	0	0.0	0.00	1.0e+00	GIT1 SMG6
Forced vital capacity (FVC), Best measure	1.75	17	8	17.8	0.10	6.6e-01	ARFGAP2 BARX1 C4orf14 CDK6 CRIPAK CYP19A1 DAB2 EBPL FHL3 GAL GIT1 HHIP-AS1 RP11-20I20.4 SAPS3 WNT4 ZNF169 ZNF438
Body fat percentage	1.09	10	6	13.3	0.04	9.2e-01	AMT CERS5 DNAH10 GIT1 HDAC5 MARK3 RERE SPTBN1 WNT2B ZHX3
Leg fat percentage (right)	1.09	9	5	11.1	-0.04	9.2e-01	AMT CERS5 DNAH10 ERI1 GIT1 RERE SGK223 WNT2B ZHX3
Arm fat-free mass (right)	2.13	28	16	35.6	0.39	2.0e-02	ABCB8 AF131215.9 B4GALNT3 C14orf39 C4orf14 CDK6 CRIPAK DAB2 DNAH10 DOCK9 EBPL ERI1 FAM66D FGFRL1 FHL3 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SIPA1 SMG6 SUPT3H TPPP3
Comparative body size at age 10	1.54	9	5	11.1	0.69	1.8e-02	CADM1 CERS5 ERI1 FAM85A FLJ10661 L3MBTL2 SAPS3 SMG6 WNT2B
Worry too long after embarrassment	1.39	4	1	2.2	-1.00	1.1e-05	AF131215.9 ERI1 FLJ10661 SGK223
Wheeze or whistling in the chest in last year	1.01	1	0	0.0	0.00	1.0e+00	RERE
Qualifications: College or University degree	0.67	3	1	2.2	0.00	1.0e+00	AMT CADM1 RERE
Medication: Blood pressure	1.31	2	0	0.0	0.00	1.0e+00	ERI1 SIPA1
Angina (self-reported)	1.19	1	0	0.0	0.00	1.0e+00	CADM1
Mean time to correctly identify matches	0.87	1	1	2.2	0.00	1.0e+00	ARFGAP2
Whole body fat mass	1.14	13	6	13.3	0.22	4.6e-01	AMT CDK6 CERS5 DNAH10 ERI1 FLJ10661 GIT1 HDAC5 MARK3 RERE SGK223 WNT2B ZHX3
Leg fat mass (right)	1.18	13	5	11.1	0.20	4.7e-01	AF131215.9 AMT CADM1 CDK6 CERS5 DNAH10 ERI1 FLJ10661 GIT1 RERE SGK223 WNT2B ZHX3
Arm predicted mass (right)	2.16	25	17	37.8	0.37	3.3e-02	ABCB8 AF131215.9 B4GALNT3 C14orf39 CDK6 CRIPAK DAB2 DNAH10 DOCK9 EBPL ERI1 FGFRL1 FHL3 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SMG6 SUPT3H WNT4
Pulse rate, automated reading	1.65	9	6	13.3	-0.06	8.6e-01	AMT CRIPAK FADS2 FAM85A LEKR1 MYH7B SERTAD2 TOMM22 ZHX3
Alcohol intake frequency.	0.77	2	0	0.0	0.00	1.0e+00	AMT TOMM22
Comparative height size at age 10	1.65	21	12	26.7	-0.02	9.2e-01	ARFGAP2 B4GALNT3 C14orf39 CAPZB CDK6 CRIPAK DAB2 DNAH10 EBPL GAL GHR HHIP-AS1 IQGAP1 MARK3 RP11-20I20.4 SAPS3 SUPT3H WARS2 WNT2B WNT4 ZNF169
Suffer from 'nerves'	1.62	3	1	2.2	-1.00	4.4e-06	AF131215.9 ERI1 FLJ10661
Chest pain or discomfort	1.02	2	0	0.0	0.00	1.0e+00	CADM1 SIPA1
Hypertension (Self-reported)	1.85	10	4	8.9	0.06	8.3e-01	AF131215.9 ARFGAP2 C6orf97 ERI1 FLJ10661 KREMEN1 RP13-514E23.2 SGK223 SIPA1 SMG6
Illnesses of father: Heart disease	1.24	1	0	0.0	0.00	1.0e+00	DNAH10
Forced expiratory volume in 1-second (FEV1), predicted	1.71	4	1	2.2	-0.17	8.3e-01	B4GALNT3 CDK6 EPDR1 HHIP-AS1
Whole body fat-free mass	2.16	28	20	44.4	0.31	6.8e-02	ABCB8 ARFGAP2 B4GALNT3 C14orf39 C1orf134 C4orf14 CDK6 CRIPAK DAB2 DNAH10 DOCK9 EBPL ERI1 FGFRL1 FHL3 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SMG6 SUPT3H TPPP3 WNT4
Leg fat-free mass (right)	1.98	25	17	37.8	0.31	9.3e-02	ABCB8 AF131215.9 ARFGAP2 B4GALNT3 C14orf39 C1orf134 CDK6 CRIPAK DAB2 DOCK9 EBPL ERI1 FHL3 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SMG6 SUPT3H WNT4
Arm fat percentage (left)	1.11	11	5	11.1	0.72	5.8e-03	AF131215.9 AMT CERS5 DNAH10 ERI1 FLJ10661 GIT1 HDAC5 MARK3 RERE SGK223
Mood swings	1.45	3	0	0.0	-0.99	1.6e-03	ERI1 FLJ10661 SGK223
Breast cancer (self-reported)	1.19	1	0	0.0	0.00	1.0e+00	C6orf97
Asthma (self-reported)	1.25	2	2	4.4	0.00	1.0e+00	FADS2 RERE
Osteoporosis (self-reported)	3.94	8	5	11.1	-0.73	3.8e-02	CPED1 DNAH10 ESPL1 GAL GREM2 LIN7C SAPS3 SPP1
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.21	3	1	2.2	0.00	1.0e+00	FAM85A HHIP-AS1 WNT4
Whole body water mass	2.15	29	20	44.4	0.34	4.4e-02	ABCB8 AF131215.9 ARFGAP2 B4GALNT3 C14orf39 C1orf134 C4orf14 CDK6 CRIPAK DAB2 DNAH10 DOCK9 EBPL ERI1 FGFRL1 FHL3 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SMG6 SUPT3H TPPP3 WNT4
Leg predicted mass (right)	1.97	24	17	37.8	0.32	8.0e-02	AF131215.9 ARFGAP2 B4GALNT3 C14orf39 C1orf134 CDK6 CRIPAK DAB2 DOCK9 EBPL ERI1 FHL3 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SMG6 SUPT3H WNT4
Arm fat mass (left)	1.16	12	5	11.1	0.63	1.6e-02	AF131215.9 AMT CADM1 CDK6 CERS5 DNAH10 ERI1 FLJ10661 GIT1 HDAC5 MARK3 SGK223
Miserableness	1.71	7	3	6.7	-0.99	1.3e-07	AF131215.9 ARFGAP2 ERI1 FAM66D FAM85A FLJ10661 SGK223
Guilty feelings	1.57	2	0	0.0	-1.00	3.5e-04	ERI1 FLJ10661
Hearing aid user	1.26	1	0	0.0	0.00	1.0e+00	AC093110.3
Eye problems/disorders: Glaucoma	1.56	1	0	0.0	0.00	1.0e+00	C14orf39
Medication: Blood pressure	1.72	4	2	4.4	0.99	1.1e-02	AF131215.9 ERI1 SIPA1 WNT2B
Medication: Bendroflumethiazide	1.64	2	1	2.2	0.00	1.0e+00	ERI1 FLJ10661
Illnesses of father: High blood pressure	1.16	1	0	0.0	0.00	1.0e+00	RP13-514E23.2
Ever smoked	0.84	1	1	2.2	0.00	1.0e+00	C4orf14
Basal metabolic rate	2.03	26	19	42.2	0.35	5.0e-02	ABCB8 AF131215.9 ARFGAP2 B4GALNT3 C14orf39 C1orf134 CDK6 CRIPAK DAB2 DOCK9 EBPL ERI1 FGFRL1 FHL3 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SMG6 SUPT3H WNT4
Leg fat percentage (left)	1.07	11	4	8.9	0.21	5.3e-01	AMT CERS5 DNAH10 ERI1 FLJ10661 GIT1 MARK3 RERE SGK223 WNT2B ZHX3
Arm fat-free mass (left)	2.07	25	15	33.3	0.33	6.8e-02	ABCB8 AF131215.9 B4GALNT3 C14orf39 CDK6 CRIPAK DAB2 DNAH10 DOCK9 EBPL ERI1 FGFRL1 FHL3 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SMG6 SUPT3H WNT4
Average weekly beer plus cider intake	1.52	3	1	2.2	-0.98	2.5e-03	ERI1 FLJ10661 SGK223
Irritability	2.24	6	4	8.9	-0.99	7.9e-08	AF131215.9 ERI1 FAM66D FAM85A FLJ10661 SGK223
Fractured/broken bones in last 5 years	5.24	10	5	11.1	-0.97	4.2e-13	C6orf97 C7orf58 CPED1 CRIPAK FAM3C FGFRL1 HDAC5 RP11-20I20.4 RSPO3 TPCN2
Diastolic blood pressure, automated reading	1.76	13	8	17.8	0.66	5.6e-03	AF131215.9 AMT ERI1 FAM66D FAM85A FLJ10661 RERE RP13-514E23.2 SGK223 SIPA1 SPTBN1 WNT2B ZHX3
Myopia	1.13	2	0	0.0	0.00	1.0e+00	BMP4 FADS2
Vascular/heart problems diagnosed by doctor	1.72	9	2	4.4	-0.09	8.0e-01	ARFGAP2 C6orf97 ERI1 FLJ10661 GIT1 KREMEN1 SGK223 SIPA1 SMG6
Cholesterol lowering medication	1.21	3	0	0.0	0.00	1.0e+00	C1orf134 DNAH10 GIT1
Basal cell carcinoma (self-reported)	1.08	1	0	0.0	0.00	1.0e+00	SAPS3
Impedance of whole body	1.94	24	16	35.6	-0.43	2.3e-02	ABCB8 AC092839.1 AF131215.9 C4orf14 CADM1 DNAH10 ERI1 FAM66D FAM85A FLJ10661 FZD7 GHR IBSP KREMEN1 L3MBTL2 MARK3 MYH7B RP11-20I20.4 RPL23AP32 SAPS3 SGK223 SMG6 WARS2 WNT2B
Leg fat mass (left)	1.20	14	5	11.1	0.29	2.8e-01	AF131215.9 AMT CADM1 CDK6 CERS5 DNAH10 ERI1 FLJ10661 GIT1 MARK3 RERE SGK223 WNT2B ZHX3
Arm predicted mass (left)	2.09	25	16	35.6	0.34	5.7e-02	ABCB8 AF131215.9 B4GALNT3 C14orf39 CDK6 CRIPAK DAB2 DNAH10 DOCK9 EBPL ERI1 FGFRL1 FHL3 FLJ10661 GAL GHR HHIP-AS1 IBSP MYH7B RP11-20I20.4 RP13-514E23.2 SAPS3 SMG6 SUPT3H TPPP3

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	22	0.63	2.4
GTEx	Adipose Visceral Omentum	18	0.88	2.5
GTEx	Adrenal Gland	6	0.41	2.2
GTEx	Artery Aorta	26	0.87	2.4
GTEx	Artery Coronary	5	0.42	2.3
GTEx	Artery Tibial	32	0.85	2.7
GTEx	Brain Caudate basal ganglia	6	0.65	2.4
GTEx	Brain Cerebellar Hemisphere	10	0.67	2.4
GTEx	Brain Cerebellum	10	0.50	2.2
GTEx	Brain Cortex	8	0.77	2.5
GTEx	Brain Frontal Cortex BA9	5	0.54	2.4
GTEx	Brain Hippocampus	2	0.38	2.6
GTEx	Brain Hypothalamus	2	0.34	2.3
GTEx	Brain Nucleus accumbens basal ganglia	4	0.46	2.2
GTEx	Brain Putamen basal ganglia	5	0.80	2.4
GTEx	Breast Mammary Tissue	12	0.61	2.5
GTEx	Breast Mammary Tissue (Male)	11	0.92	2.3
GTEx	Breast Mammary Tissue (Female)	9	0.55	2.3
GTEx	Cells EBV-transformed lymphocytes	8	0.56	2.4
GTEx	Cells Transformed fibroblasts	21	0.50	2.3
GTEx	Colon Sigmoid	4	0.27	2.3
GTEx	Colon Transverse	17	0.82	2.2
GTEx	Esophagus Gastroesophageal Junction	12	0.83	2.4
GTEx	Esophagus Mucosa	21	0.63	2.3
GTEx	Esophagus Muscularis	22	0.68	2.3
GTEx	Heart Atrial Appendage	10	0.63	2.3
GTEx	Heart Left Ventricle	11	0.72	2.4
GTEx	Liver	2	0.28	2.1
GTEx	Lung	20	0.70	2.4
GTEx	Muscle Skeletal	12	0.42	2.1
GTEx	Nerve Tibial	31	0.72	2.4
GTEx	Ovary	4	0.44	2.5
GTEx	Pancreas	19	1.16	2.7
GTEx	Pituitary	4	0.36	2.3
GTEx	Prostate	7	0.84	2.5
GTEx	Skin Not Sun Exposed Suprapubic	19	0.77	2.5
GTEx	Skin Sun Exposed Lower leg	24	0.66	2.5
GTEx	Small Intestine Terminal Ileum	2	0.43	2.5
GTEx	Spleen	9	0.64	2.4
GTEx	Stomach	9	0.62	2.3
GTEx	Testis	23	0.73	2.3
GTEx	Thyroid	22	0.55	2.4
GTEx	Uterus	4	0.71	2.6
GTEx	Vagina	4	0.63	2.4
GTEx	Whole Blood	13	0.65	2.2
METSIM	Adipose	29	0.63	2.2
NTR	Blood	21	0.87	2.4
ROSMAP	Brain Pre-frontal Cortex	42	0.96	2.5
YFS	Blood	19	0.41	2.0
CommonMind	Brain Pre-frontal Cortex	33	0.61	2.2
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	11	0.66	2.4
The Cancer Genome Atlas	Breast Invasive Carcinoma	38	0.86	2.4
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	6	0.55	2.1
The Cancer Genome Atlas	Colon Adenocarcinoma	17	0.82	2.3
The Cancer Genome Atlas	Esophageal Carcinoma	5	0.73	2.2
The Cancer Genome Atlas	Glioblastoma Multiforme	7	0.68	2.5
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	17	0.62	2.2
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	31	0.76	2.2
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	15	0.73	2.2
The Cancer Genome Atlas	Brain Lower Grade Glioma	26	0.60	2.2
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	3	0.27	2.1
The Cancer Genome Atlas	Lung Adenocarcinoma	14	0.48	2.2
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	12	0.48	2.2
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	10	0.63	2.5
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	12	0.72	2.5
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	15	1.13	2.4
The Cancer Genome Atlas	Prostate Adenocarcinoma	26	0.56	2.2
The Cancer Genome Atlas	Rectum Adenocarcinoma	4	0.58	2.1
The Cancer Genome Atlas	Soft Tissue Sarcoma	7	0.66	2.3
The Cancer Genome Atlas	Skin Cutaneous Melanoma	4	0.75	2.5
The Cancer Genome Atlas	Stomach Adenocarcinoma	13	0.77	2.3
The Cancer Genome Atlas	Testicular Germ Cell Tumors	8	0.63	2.1
The Cancer Genome Atlas	Thyroid Carcinoma	26	0.50	2.1
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	4	0.79	2.5